Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001962334 | SCV002137261 | pathogenic | Qualitative or quantitative defects of dysferlin | 2021-11-15 | criteria provided, single submitter | clinical testing | This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Arg1821*) in the DYSF gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DYSF are known to be pathogenic (PMID: 17698709, 20301480). This premature translational stop signal has been observed in individual(s) with miyoshi myopathy (PMID: 25591676). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV004571456 | SCV005060285 | pathogenic | Miyoshi muscular dystrophy 1 | 2024-01-02 | criteria provided, single submitter | clinical testing |